Inactive Instrument

MarketScreener Strategies Actavis PLC Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

Mar. 05	Allergan Aesthetics Announces the U.S. FDA Approval of JUVEDERM VOLUMA XC for Injection in the Temple Region to Improve Moderate to Severe Temple Hollowing in Adults over the Age of 21	CI
2023	Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of Onabotulinumtoxina for the Treatment of Platysma Prominence	CI

No results for this search